Evidence map›Paper›PMID 42116415›Full record

ArticleMedicine2026

Comparison of clinical outcomes of reperfusion therapies in in-hospital and community-onset acute ischemic stroke: A retrospective cohort study.

Cemile Haki, Tugce Yavas, Gulcin Koc Yamanyar, Kaya Sarac, Suat Kamisli

Abstract readComparative Study
In one paragraph

Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cemile HakiDepartment of Neurology, University of Health Sciences, Bursa City Hospital, Bursa, Turkiye.ORCID 0000-0002-9679-8007
Tugce YavasDepartment of Neurology, University of Health Sciences, Bursa City Hospital, Bursa, Turkiye.ORCID 0009-0003-0779-5627
Gulcin Koc YamanyarDepartment of Neurology, University of Health Sciences, Neurocritical Care Unit, Bursa City Hospital, Bursa, Turkiye.ORCID 0000-0002-4929-8181
Kaya SaracDepartment of Radiology, University of Health Sciences, Bursa City Hospital, Bursa, Turkiye.ORCID 0000-0001-5559-3219
Suat KamisliDepartment of Neurology, University of Health Sciences, Bursa City Hospital, Bursa, Turkiye.ORCID 0000-0003-4281-3301

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In-hospital acute ischemic stroke (AIS) is a distinct clinical entity that may differ from community-onset AIS in terms of patient characteristics, treatment processes, and outcomes. This study aimed to compare the clinical features, treatment pathways, and functional outcomes of patients with in-hospital versus community-onset AIS who received recanalization therapies. This retrospective analysis included adult patients with AIS treated with intravenous tissue plasminogen activator and/or mechanical thrombectomy (MT) at a single center between July 2020 and January 2025. The patients were stratified based on whether stroke occurred during hospitalization or in the community. Patient demographics, treatment strategies, procedural time intervals, recanalization success, and clinical outcomes were assessed. The in-hospital stroke group had a higher prevalence of cardiac disease and malignancy. The patients in this group underwent groin puncture sooner after symptom onset, and all those who underwent MT achieved successful recanalization. Nevertheless, the rates of favorable functional recovery at 3 months (modified rankin scale ≤ 2) and in-hospital mortality were similar between the in-hospital and community-onset stroke groups. In-hospital stroke was not identified as a significant predictor of 3-month functional outcome in the multivariate analysis. Among patients who received recanalization therapies, in-hospital AIS cases (despite a higher comorbidity burden) can achieve clinical outcomes similar to those of community-onset strokes through early recognition and treatment initiation. These findings highlight the importance of structured in-hospital stroke protocols and the role of MT in in-hospital stroke management.

Indexed as

Ischemic StrokeReperfusionTissue Plasminogen ActivatorAgedAged, 80 and overBrain IschemiaFemaleFibrinolytic AgentsHospitalizationHospital MortalityHumansMaleMiddle AgedRetrospective StudiesThrombectomyTreatment OutcomeFibrinolytic AgentsTissue Plasminogen Activatoracute ischemic strokein-hospital strokemechanical thrombectomyrecanalization therapiestreatment outcomes

Identifiers

PMID42116415
PMCPMC13166792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.